Victory Capital Management’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-4,125
| Closed | -$14K | – | 3806 |
|
|
2019
Q4 | $14K | Hold |
4,125
| – | – | ﹤0.01% | 2619 |
|
|
2019
Q3 | $13K | Hold |
4,125
| – | – | ﹤0.01% | 3188 |
|
|
2019
Q2 | $10K | Hold |
4,125
| – | – | ﹤0.01% | 1811 |
|
|
2019
Q1 | $15K | Hold |
4,125
| – | – | ﹤0.01% | 1753 |
|
|
2018
Q4 | $15K | Hold |
4,125
| – | – | ﹤0.01% | 1751 |
|
|
2018
Q3 | $24K | Buy |
4,125
+542
| +15% | +$3.1K | ﹤0.01% | 1751 |
|
|
2018
Q2 | $18K | Hold |
3,583
| – | – | ﹤0.01% | 1801 |
|
|
2018
Q1 | $18K | Hold |
3,583
| – | – | ﹤0.01% | 1797 |
|
|
2017
Q4 | $22K | Sell |
3,583
-3,669
| -51% | -$22.1K | ﹤0.01% | 1782 |
|
|
2017
Q3 | $40K | Hold |
7,252
| – | – | ﹤0.01% | 1755 |
|
|
2017
Q2 | $34K | Buy |
7,252
+2,941
| +68% | +$13.1K | ﹤0.01% | 1750 |
|
|
2017
Q1 | $21K | Buy |
4,311
+2,313
| +116% | +$22.3K | ﹤0.01% | 1775 |
|
|
2016
Q4 | $22K | Buy |
1,998
+111
| +6% | +$1.04K | ﹤0.01% | 1755 |
|
|
2016
Q3 | $17K | Buy |
1,887
+127
| +7% | +$1.06K | ﹤0.01% | 1759 |
|
|
2016
Q2 | $11K | Buy |
1,760
+70
| +4% | +$465 | ﹤0.01% | 1621 |
|
|
2016
Q1 | $11K | Buy |
1,690
+132
| +8% | +$851 | ﹤0.01% | 1648 |
|
|
2015
Q4 | $13K | Buy |
1,558
+85
| +6% | +$635 | ﹤0.01% | 1665 |
|
|
2015
Q3 | $11K | Buy |
1,473
+131
| +10% | +$1.33K | ﹤0.01% | 1606 |
|
|
2015
Q2 | $14K | Buy |
+1,342
| New | +$14.8K | ﹤0.01% | 1612 |
|
Victory Capital Management's FOMX Position: Q1 2020 in Review
Victory Capital Management sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q1 2020, closing a stake of 4,125 shares — an estimated $14K sold.
Victory Capital Management first reported a position in FOMX in Q2 2015 and held it in 19 quarters. The position peaked at $40K in Q3 2017. 3 funds tracked by Wall St. Rank hold FOMX as of Q1 2020.
- Victory Capital Management reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q1 2020 after selling out during the quarter.
- Victory Capital Management sold 4,125 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q1 2020, an estimated $14K.
- Victory Capital Management first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q2 2015 and held it in 19 quarters.
- Victory Capital Management's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $40K in Q3 2017.
- 3 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q1 2020.
Based on Victory Capital Management's 13F filing for Q1 2020, filed 4 May 2020.